A cost efficiency analysis of outpatient ophthalmic procedures has been published in American Journal of Ophthalmology. The purpose of the study, state the researchers, was to “evaluate the financial feasibility” of nine common ophthalmic procedures performed at ASCs and HOPDs relative to Medicare facility reimbursement in 2025.
The study proposes a “novel framework to analyze ASCs and HOPDs based on maximum intraoperative time to maintain financial neutrality." The results indicate that “ASCs are well-positioned to offer common ophthalmic surgical procedures in a financially efficient manner.” The researchers add that their model finds that “Medicare reimbursement relative to direct material cost per procedure was the main driver of maximum intraoperative time, highlighting the unique financial considerations ASCs may face due to limitations on reimbursement and lower Medicare facility fees compared to HOPDs.”
Access the full study here.
